John Leaman
Net worth: - $ as of 2024-02-28
Profile
John Harold Leaman is former Chief Financial Officer at Impel Pharmaceuticals, Inc., former Chief Financial Officer & Head-Corporate Strategy at Selecta Biosciences, Inc., former Associate Principal at McKinsey & Co., Inc., former Principal at Devon Park Bioventures, former Chief Financial Officer for Aevi Genomic Medicine, Inc. and former Head-Corporate Development at InfaCare Pharmaceutical Corp.
He received an undergraduate degree from Elizabethtown College, a doctorate from Perelman School of Medicine, an MBA from The Wharton School of the University of Pennsylvania and a graduate degree from Oriel College.
Known holdings in public companies
Company | Date | Number of shares | Valuation | Valuation date |
---|---|---|---|---|
2023-03-14 | 0 ( -.--% ) | - $ | 2024-02-28 |
Former positions of John Leaman
Companies | Position | End |
---|---|---|
IPI LEGACY LIQUIDATION CO | Director of Finance/CFO | 2023-03-09 |
CARTESIAN THERAPEUTICS, INC. | Director of Finance/CFO | 2019-03-30 |
InfaCare Pharmaceutical Corp.
InfaCare Pharmaceutical Corp. BiotechnologyHealth Technology InfaCare Pharmaceutical Corp. develops and commercializes proprietary pharmaceuticals for the neonatal and pediatric patient population. It offers Stanate, a heme oxygenase inhibitor for the treatment of infantile jaundice or hyperbilirubinemia. The company was founded by Robert A. Vukovich on July 5, 2005 and is headquartered in Trevose, PA. | Corporate Officer/Principal | 2017-08-31 |
AEVI GENOMIC MEDICINE, INC. | Director of Finance/CFO | 2016-02-08 |
McKinsey & Co., Inc.
McKinsey & Co., Inc. Miscellaneous Commercial ServicesCommercial Services McKinsey & Co., Inc. provides management consulting services. It specializes in design, marketing and sales, analytics, operations, transformation and restructuring, risk, strategy and corporate finance, and sustainability and resource productivity. The company was founded by James O. McKinsey in 1926 and is headquartered in New York, NY. | Corporate Officer/Principal | - |
Training of John Leaman
Elizabethtown College | Undergraduate Degree |
Oriel College | Graduate Degree |
The Wharton School of the University of Pennsylvania | Masters Business Admin |
Perelman School of Medicine | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 1 |
---|---|
IPI LEGACY LIQUIDATION CO | Health Technology |
Private companies | 5 |
---|---|
InfaCare Pharmaceutical Corp.
InfaCare Pharmaceutical Corp. BiotechnologyHealth Technology InfaCare Pharmaceutical Corp. develops and commercializes proprietary pharmaceuticals for the neonatal and pediatric patient population. It offers Stanate, a heme oxygenase inhibitor for the treatment of infantile jaundice or hyperbilirubinemia. The company was founded by Robert A. Vukovich on July 5, 2005 and is headquartered in Trevose, PA. | Health Technology |
Selecta Biosciences, Inc.
Selecta Biosciences, Inc. BiotechnologyHealth Technology Selecta Biosciences, Inc. is a clinical-stage biopharmaceutical company, which engages in the research and development of nanoparticle immunomodulatory drugs for the treatment and prevention of human diseases. Its portfolio includes pipeline, autoimmune, gene therapy, and biologic therapy. The company was founded by Omid C. Farokhzad, Robert S. Langer Jr., and Ulrich von Andrian on December 10, 2007 and is headquartered in Watertown, MA. | Health Technology |
McKinsey & Co., Inc.
McKinsey & Co., Inc. Miscellaneous Commercial ServicesCommercial Services McKinsey & Co., Inc. provides management consulting services. It specializes in design, marketing and sales, analytics, operations, transformation and restructuring, risk, strategy and corporate finance, and sustainability and resource productivity. The company was founded by James O. McKinsey in 1926 and is headquartered in New York, NY. | Commercial Services |
Aevi Genomic Medicine, Inc.
Aevi Genomic Medicine, Inc. Pharmaceuticals: MajorHealth Technology Aevi Genomic Medicine, Inc. is a clinical stage biopharmaceutical company, which engaged in the discovery of treatments for rare and orphan diseases. Its research and development efforts leverage an internal genomics platform and an ongoing collaboration with the Center for Applied Genomics (CAG) at The Children's Hospital of Philadelphia (CHOP). The company was founded by Andrew Leonard Pearlman on January 27, 2000 and is headquartered in Wayne, PA. | Health Technology |
Devon Park Bioventures
Devon Park Bioventures Investment ManagersFinance Devon Park Bioventures (Devon Park Bioventures) is a venture capital firm founded in 2006. The firm is headquartered in Pennsylvania, United States. | Finance |